News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2023-11-10 7:18:2 pm Panbela Therapeutics, Inc. (PBLA) Q3 2023 Earnings Call Transcript SeekingAlpha
2023-11-09 1:10:0 pm Panbela Provides Business Update and Reports Q3 2023 Financial Results GlobeNewswire
2023-11-03 4:55:0 am Panbela Therapeutics Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $1.9 Million Gross Proceeds Priced At-the-Market GlobeNewswire
2023-11-02 5:15:0 am Panbela Announces Publication of Preclinical and Clinical Data Titled: Inhibition of Polyamine Biosynthesis Preserves β Cell Function in Type 1 Diabetes GlobeNewswire
2023-10-31 5:15:0 am Panbela Announces Validation of European Patent in UK, Italy, Germany, France, and Spain for Claims of a Novel Process for the Production of SBP-101 GlobeNewswire
2023-10-25 5:15:0 am Acceptance of Polyamine Inhibitor CAR-T Combination Abstract for Online Publication GlobeNewswire
2023-10-24 5:15:0 am Panbela to Host Third Quarter 2023 Earnings Conference Call on November 9, 2023 GlobeNewswire
2023-09-26 5:15:0 am Panbela Announces Issuance of New Patent in China for Claims of a Novel Process for the Production of SBP-101 GlobeNewswire
2023-09-19 5:15:0 am Panbela to Present at the LD Micro Investor Conference GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information